STADA NORDIC ApS: Financial statements 2014
CVR: 13902992
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
STADA NORDIC ApS (CVR 13902992) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 224,497,779 and a net result of DKK 8,030,951. The profit margin was 3.6%. Equity in the 2014 report amounted to DKK 107,161,047. The solvency ratio was 65%. The company had 18 employees in the financial year.
- Revenue
- DKK 224,497,779
- Gross Profit
- DKK 54,591,810
- Profit/Loss
- DKK 8,030,951
- Equity
- DKK 107,161,047
- Total Assets
- DKK 164,923,712
- Employees
- 18
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
On October 21, 2014, the company changed its name from PHARMACODANE ApS to STADA NORDIC ApS.
STADA NORDIC ApS has published its annual report for 2013.
About STADA NORDIC ApS
STADA NORDIC ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 1990. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMACODANE ApS and ApS KBIL 15 NR. 1160. The management consists of Inge-Merete Larsen. The board consists of Berit Goldmann. The company is owned by BEPHA Beteiligungsgesellschaft für Pharmawerte GmbH. The company has 49 employees (2026). In 2025, the company reported revenue of DKK 1,296,878,325 and a net result of DKK 54,568,326 compared with DKK 46,128,280 the year before. Equity in the 2025 report amounted to DKK 346,297,970.